Patents by Inventor MICHELLE DELANOY

MICHELLE DELANOY has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • BORRELIA IMMUNOASSAYS AND MATERIALS THEREFOR
    Publication number: 20220137047
    Abstract: The present invention relates to an immunoassay for the detection of Borrelia specific IgG, IgM and IgG/IgM antibodies in biological samples suspected of Lyme infection. The immunoassay can be performed via a standard immunoassay format or on an automated platform. In various embodiments, the immunoassay uses one or more Borrelia specific chimeric peptides VlsE-FlaB (designated pFlaB-mV), VlsE-ErpP (designated pErp59-mV), VlsE-P35 (designated pP35-mV) alone or in combination with one or more outer surface protein C (Osp C) types B or I, p58 and DbpA. Other aspects of the invention provide antigen/substrate combinations and compositions comprising combinations of the disclosed peptides and/or proteins for use in the immunoassays described herein.
    Type: Application
    Filed: December 27, 2021
    Publication date: May 5, 2022
    Inventors: MICHELLE DELANOY, JOHN FLANAGAN, AUDREY ARJOMANDI, RAVI KAUL, STEVEN R. BINDER
  • immunoassays and materials therefor
    Patent number: 11209431
    Abstract: The present invention relates to an immunoassay for the detection of Borrelia specific IgG, IgM and IgG/IgM antibodies in biological samples suspected of Lyme infection. The immunoassay can be performed via a standard immunoassay format or on an automated platform. In various embodiments, the immunoassay uses one or more Borrelia specific chimeric peptides VlsE-FlaB (designated pFlaB-mV), VlsE-ErpP (designated pErp59-mV), VlsE-P35 (designated pP35-mV) alone or in combination with one or more outer surface protein C (Osp C) types B or I, p58 and DbpA. Other aspects of the invention provide antigen/substrate combinations and compositions comprising combinations of the disclosed peptides and/or proteins for use in the immunoassays described herein.
    Type: Grant
    Filed: October 6, 2016
    Date of Patent: December 28, 2021
    Assignee: BIO-RAD LABORATORIES, INC.
    Inventors: Michelle Delanoy, John Flanagan, Audrey Arjomandi, Ravi Kaul, Steven R. Binder
  • BORRELIA IMMUNOASSAYS AND MATERIALS THEREFOR
    Publication number: 20190025303
    Abstract: The present invention relates to an immunoassay for the detection of Borrelia specific IgG, IgM and IgG/IgM antibodies in biological samples suspected of Lyme infection. The immunoassay can be performed via a standard immunoassay format or on an automated platform. In various embodiments, the immunoassay uses one or more Borrelia specific chimeric peptides VlsE-FlaB (designated pFlaB-mV), VlsE-ErpP (designated pErp59-mV), VlsE-P35 (designated pP35-mV) alone or in combination with one or more outer surface protein C (Osp C) types B or I, p58 and DbpA. Other aspects of the invention provide antigen/substrate combinations and compositions comprising combinations of the disclosed peptides and/or proteins for use in the immunoassays described herein.
    Type: Application
    Filed: October 6, 2016
    Publication date: January 24, 2019
    Inventors: MICHELLE DELANOY, JOHN FLANAGAN, AUDREY ARJOMANDI, RAVI KAUL, STEVEN R. BINDER